Tapewire

Nasdaq · USD

MRNA

Moderna, Inc.

Export transactions ↓
Tapewire entity
2025
SEC CIK
0001682852
Parsed reports
1,064

Last 12 months

Inside the activity.

0 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202600
Feb 202601
Mar 202601
Apr 202600
May 202603
Jun 202602
Jul 202601
Aug 202604
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 28, 2024 Filed May 30, 2024 20:14 UTC
Hoge StephenPresident
Exercise / conversionCommon Stock 610 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-016963 · form4.xml · nonDerivative · entry 1

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,472,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
May 28, 2024 Filed May 30, 2024 20:36 UTC
Mock James MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 328 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-016987 · form4.xml · derivative · entry 3

Mock James M · CIK 0001736359 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,617

Underlying: Common Stock · 328 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 28, 2024 Filed May 30, 2024 20:36 UTC
Mock James MChief Financial Officer
Exercise / conversionCommon Stock 328 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-016987 · form4.xml · nonDerivative · entry 1

Mock James M · CIK 0001736359 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:12 UTC
Klinger Shannon ThymeChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 2,652 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-016773 · form4.xml · derivative · entry 3

Klinger Shannon Thyme · CIK 0001866132 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,957

Underlying: Common Stock · 2,652 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.

F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:12 UTC
Klinger Shannon ThymeChief Legal Officer
Exercise / conversionCommon Stock 2,652 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-016773 · form4.xml · nonDerivative · entry 1

Klinger Shannon Thyme · CIK 0001866132 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,919

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:16 UTC
Mock James MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,326 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-016777 · form4.xml · derivative · entry 3

Mock James M · CIK 0001736359 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,978

Underlying: Common Stock · 1,326 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.

F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:16 UTC
Mock James MChief Financial Officer
Exercise / conversionCommon Stock 1,326 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-016777 · form4.xml · nonDerivative · entry 1

Mock James M · CIK 0001736359 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 97 $164.67 $15,972.99
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 19

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,981,931

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 625 $163.92 $102,450.75
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 18

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,982,028

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.67 to $164.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 2,223 $163.02 $362,401.46
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 17

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,982,653

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.58 to $163.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 1,005 $162.19 $163,002.76
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 16

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,984,876

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.55 to $162.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 825 $160.24 $132,194.29
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 15

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,985,881

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.99 to $160.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 2,200 $159.57 $351,050.26
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 14

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,986,706

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.90 to $159.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 1,923 $158.25 $304,320.33
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 13

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,988,906

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.89 to $158.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 1,802 $157.41 $283,655.88
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 12

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,990,829

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.73 to $157.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 600 $155.66 $93,396.00
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 11

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,992,631

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.26 to $156.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 200 $153.84 $30,768.00
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 10

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,993,231

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.62 to $154.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 800 $152.92 $122,336.00
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 9

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,993,431

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.44 to $153.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 700 $151.73 $106,213.03
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 8

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,994,231

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.42 to $152.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 400 $150.60 $60,238.00
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 7

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,994,931

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.18 to $151.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 300 $149.45 $44,835.99
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 6

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,995,331

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $149.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 600 $148.21 $88,924.02
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 5

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,995,631

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.91 to $148.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 300 $147.06 $44,118.99
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 4

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,996,231

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.53 to $147.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 100 $145.03 $14,503.00
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 3

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,996,531

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 200 $144.40 $28,879.00
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 2

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,996,631

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.95 to $144.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:00 UTC SaleCommon Stock 100 $142.95 $14,295.00
Disclosure

SEC source: 0000950170-24-064806 · ownership.xml · nonDerivative · entry 1

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,996,831

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

Read SEC document
May 15, 2024 Filed May 17, 2024 20:04 UTC
Hoge StephenPresident
SaleCommon Stock 15,000 $127.49 $1,912,350.00
Disclosure

SEC source: 0001127602-24-015809 · form4.xml · nonDerivative · entry 1

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,471,508

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2023.

Read SEC document
May 15, 2024 Filed May 17, 2024 23:00 UTC SaleCommon Stock 200 $129.15 $25,830.00
Disclosure

SEC source: 0000950170-24-062016 · ownership.xml · nonDerivative · entry 5

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,996,931

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.14 to $129.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 15, 2024 Filed May 17, 2024 23:00 UTC SaleCommon Stock 5,711 $128.75 $735,271.83
Disclosure

SEC source: 0000950170-24-062016 · ownership.xml · nonDerivative · entry 4

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,997,131

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.13 to $129.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 15, 2024 Filed May 17, 2024 23:00 UTC SaleCommon Stock 2,600 $127.71 $332,036.38
Disclosure

SEC source: 0000950170-24-062016 · ownership.xml · nonDerivative · entry 3

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,002,842

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.13 to $128.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 15, 2024 Filed May 17, 2024 23:00 UTC SaleCommon Stock 2,001 $126.62 $253,368.22
Disclosure

SEC source: 0000950170-24-062016 · ownership.xml · nonDerivative · entry 2

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,005,442

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.12 to $127.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 15, 2024 Filed May 17, 2024 23:00 UTC SaleCommon Stock 4,488 $125.53 $563,356.65
Disclosure

SEC source: 0000950170-24-062016 · ownership.xml · nonDerivative · entry 1

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,007,443

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.08 to $126.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 10, 2024 Filed May 13, 2024 20:03 UTC
Hoge StephenPresident
SaleCommon Stock 255 $120.96 $30,844.11
Disclosure

SEC source: 0001127602-24-015081 · form4.xml · nonDerivative · entry 2

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,486,508

F2 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:03 UTC
Hoge StephenPresident
Exercise / conversionRestricted Stock Units · Derivative 522 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-015081 · form4.xml · derivative · entry 5

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,568

Underlying: Common Stock · 522 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 09, 2024 Filed May 13, 2024 20:03 UTC
Hoge StephenPresident
Exercise / conversionCommon Stock 522 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-015081 · form4.xml · nonDerivative · entry 1

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,486,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
May 08, 2024 Filed May 10, 2024 23:00 UTC SaleCommon Stock 7,996 $122.07 $976,062.92
Disclosure

SEC source: 0000950170-24-058065 · ownership.xml · nonDerivative · entry 3

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,011,931

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.84 to $122.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 08, 2024 Filed May 10, 2024 23:00 UTC SaleCommon Stock 5,004 $121.59 $608,416.34
Disclosure

SEC source: 0000950170-24-058065 · ownership.xml · nonDerivative · entry 2

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,019,927

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.83 to $121.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 08, 2024 Filed May 10, 2024 23:00 UTC SaleCommon Stock 2,000 $120.37 $240,741.00
Disclosure

SEC source: 0000950170-24-058065 · ownership.xml · nonDerivative · entry 1

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,024,931

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.79 to $120.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:59 UTC
SAGAN PAULDirector
GrantStock Option (Right to Buy) · Derivative 7,557 $0.00 Strike: $122.13 $0.00
Disclosure

SEC source: 0001127602-24-014470 · form4.xml · derivative · entry 1

SAGAN PAUL · CIK 0001035440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,557

Underlying: Common Stock · 7,557 shares

Expires 2034-05-06

F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 21:10 UTC GrantStock Option (Right to Buy) · Derivative 7,557 $0.00 Strike: $122.13 $0.00
Disclosure

SEC source: 0001127602-24-014476 · form4.xml · derivative · entry 3

Berenson Stephen · CIK 0001760671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,557

Underlying: Common Stock · 7,557 shares

Expires 2034-05-06

F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 21:02 UTC GrantStock Option (Right to Buy) · Derivative 7,557 $0.00 Strike: $122.13 $0.00
Disclosure

SEC source: 0001127602-24-014472 · form4.xml · derivative · entry 1

Nader Francois · CIK 0001365343 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,557

Underlying: Common Stock · 7,557 shares

Expires 2034-05-06

F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:57 UTC GrantStock Option (Right to Buy) · Derivative 7,557 $0.00 Strike: $122.13 $0.00
Disclosure

SEC source: 0001127602-24-014468 · form4.xml · derivative · entry 1

Tallett Elizabeth E · CIK 0001192460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,557

Underlying: Common Stock · 7,557 shares

Expires 2034-05-06

F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:54 UTC GrantRestricted Stock Units · Derivative 979 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-014466 · form4.xml · derivative · entry 2

Horning Sandra · CIK 0001638709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 979

Underlying: Common Stock · 979 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

F3 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:54 UTC GrantStock Option (Right to Buy) · Derivative 5,668 $0.00 Strike: $122.13 $0.00
Disclosure

SEC source: 0001127602-24-014466 · form4.xml · derivative · entry 1

Horning Sandra · CIK 0001638709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,668

Underlying: Common Stock · 5,668 shares

Expires 2034-05-06

F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:51 UTC GrantStock Option (Right to Buy) · Derivative 7,557 $0.00 Strike: $122.13 $0.00
Disclosure

SEC source: 0001127602-24-014459 · form4.xml · derivative · entry 1

LANGER ROBERT · CIK 0001239757 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,557

Underlying: Common Stock · 7,557 shares

Expires 2034-05-06

F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:48 UTC GrantRestricted Stock Units · Derivative 979 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-014456 · form4.xml · derivative · entry 4

NABEL ELIZABETH G · CIK 0001619929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 979

Underlying: Common Stock · 979 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

F4 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:48 UTC GrantStock Option (Right to Buy) · Derivative 5,668 $0.00 Strike: $122.13 $0.00
Disclosure

SEC source: 0001127602-24-014456 · form4.xml · derivative · entry 3

NABEL ELIZABETH G · CIK 0001619929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,668

Underlying: Common Stock · 5,668 shares

Expires 2034-05-06

F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:42 UTC GrantStock Option (Right to Buy) · Derivative 7,557 $0.00 Strike: $122.13 $0.00
Disclosure

SEC source: 0001127602-24-014450 · form4.xml · derivative · entry 1

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,557

Underlying: Common Stock · 7,557 shares

Expires 2034-05-06

F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Read SEC document
May 03, 2024 Filed May 7, 2024 21:10 UTC Exercise / conversionRestricted Stock Units · Derivative 732 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-014476 · form4.xml · derivative · entry 2

Berenson Stephen · CIK 0001760671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 732 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on May 3, 2024.

F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on May 3, 2024.

Read SEC document
May 03, 2024 Filed May 7, 2024 21:10 UTC Exercise / conversionCommon Stock 732 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-014476 · form4.xml · nonDerivative · entry 1

Berenson Stephen · CIK 0001760671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,203

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.